The Lung Cancer Center specializes in the full-cycle management of pulmonary nodule differentiation, non-small cell lung cancer, small cell lung cancer and related disorders. Supported by cutting-edge technologies including low-dose spiral CT early screening, genetic testing and liquid biopsy, the center routinely performs VATS, SBRT, targeted therapy and immunotherapy, delivering precise, personalized one-stop diagnosis and treatment. Boasting outstanding surgical capabilities, the center has built an MDT platform for multi-line therapy of advanced lung cancer. By integrating surgical, radiation, medical oncology and innovative drug treatment resources, we deliver continuously optimized comprehensive regimens tailored to patients of all stages and individual clinical needs.

The center also excels in minimally invasive surgery and comprehensive management of complex thoracic disorders, including esophageal cancer, gastric cardia cancer, lung cancer and mediastinal tumors.

Expert Team: Zhang Shucai, Zhang Lijian, Li Li, Li Jian, Li Yin, Gao Xiaofang, Pei Yingxin, Zhang Min, Xu Peiran, etc.

The center is dedicated to precision diagnosis and treatment of gastrointestinal malignancies, stromal tumors, and other digestive tract cancers. Leveraging precise molecular subtyping based on genetic testing, we deliver accurate targeted therapy and provide fully individualized, stage-adapted treatment plans throughout the care continuum. These include endoscopic resection for early-stage tumors, laparoscopic minimally invasive surgery and neoadjuvant therapy for locally advanced disease, molecular targeted therapy for gastrointestinal stromal tumors (GISTs), as well as comprehensive treatment and nutritional support for advanced-stage cancer.

In addition, the center offers novel therapeutic technologies such as cellular therapy and fecal microbiota transplantation (FMT), committed to providing patients with standardized, full-spectrum diagnostic and treatment services.

Target Diseases: Standardized surgical management of gastric cancer, colon cancer, rectal cancer, and gastrointestinal stromal tumors (GISTs).

Expert Team: Ma Zhiqiang, Bai Li, Liu Zheng, Xie Jiangping, Wu Xin, Liu Chaoqun, Li Linyan

The center is dedicated to the precise diagnosis, surgical intervention, and systematic comprehensive treatment of breast tumors. With advanced techniques such as breast-conserving surgery, breast reconstruction, and neoadjuvant therapy as the core, we integrate the principles of surgical oncology and plastic and reconstructive surgery. While pursuing radical tumor resection, we take into account the preservation of patients' body image and psychological recovery.

With surgical technology as the cornerstone, the center emphasizes the coherent connection between postoperative rehabilitation and personalized adjuvant therapy. Relying on the MDT model, we provide full-cycle management for patients from initial diagnosis, treatment to long-term follow-up, and strive to achieve a balance between medical professionalism and humanistic care, helping every patient achieve holistic physical and psychological recovery.

Target Diseases: Breast cancer, triple-negative breast cancer, papillary carcinoma of the breast, intraductal papilloma of the breast, lobular carcinoma in situ (LCIS), malignant breast neoplasms, breast fibroadenoma.

Expert Team: Sun Min, Li Jinfeng, Song Guohong, Wang Shu, Pan Yong, Wang Jing

The center focuses on the refined diagnosis, treatment and whole-process management of gynecological malignant tumors such as cervical cancer, ovarian cancer and endometrial cancer.

Taking high-difficulty oncological surgery as its technical core, it specializes in individualized surgical procedures including fertility-preserving surgery and laparoscopic minimally invasive surgery. It is committed to maximally protecting women’s physiological function and quality of life while curing the disease.

For patients with recurrent or refractory gynecological tumors, relying on the MDT model, the center integrates comprehensive treatment strategies including surgery, chemotherapy, targeted therapy and immunotherapy, providing new treatment options and hope for complex cases. It also provides genetic counseling and professional risk assessment for gynecological tumors, and conducts standardized preventive intervention for high-risk groups to fully safeguard women’s health.

Target Diseases: Cervical cancer, ovarian cancer, vulvar cancer, recurrent ovarian cancer, and endometrial cancer.

Expert Team: Wu Ming, Pan Lingya, Gao Yunong, Tan Xianjie, Zhong Sen, Yu Jie, Yu Mei

Focusing on neurological diseases such as gliomas, brain metastases, and spinal canal tumors, the center has introduced neuronavigation and intraoperative neurophysiological monitoring systems. It performs precision procedures including awake craniotomy and laser interstitial thermal therapy, and develops personalized surgical and comprehensive treatment plans for each patient. This approach maximizes the preservation of neurological function and improves patients’ quality of life.

Target conditions: Skull base tumors, brainstem tumors, and intramedullary spinal cord tumors

Expert Team: Zhang Juntao, Zhang Hongqi, Wu Zhen, Jiang Yun, Wu Hao, Zhang Hongjun, Liu Han

Specializing in complex hepatobiliary and pancreatic diseases—including liver cancer, liver metastases, cholangiocarcinoma, pancreatic cancer, and gallbladder cancer—the center is centered on MDT collaboration. It integrates the combined strengths of surgery, interventional therapy, and medical oncology to deliver personalized, whole-course, and international-standard comprehensive care.

The center performs advanced procedures such as laparoscopic precise hepatectomy, radical pancreatectomy, simultaneous and staged resection for colorectal liver metastases, as well as TACE, radiofrequency ablation, and 3D conformal radiotherapy. It is committed to maximizing survival benefits and quality of life for every patient.

Target Diseases:Primary liver cancer, liver metastatic carcinoma, cholangiocarcinoma, benign and malignant pancreatic tumors, and benign and malignant splenic tumors

Expert Team: Jiang Bin, Hao Chunyi, Lu Xin, Yuan Chunhui, Chen Lei, Zhao Haitao, Zhang Yefan, Han Chun, Tan Mingkun

Specializing in urogenital tumors including renal tumors, ureteral cancer, bladder cancer and prostate cancer, as well as adrenal endocrine tumors and cancer patients with cardiovascular and cerebrovascular comorbidities.

The center routinely performs advanced minimally invasive procedures such as laparoscopic and endoscopic surgery, along with cryoablation. Through precise diagnosis, it delivers minimally invasive, standardized and efficient treatment regimens tailored for patients.

Target Diseases: Bladder cancer, renal tumors, prostate cancer, upper urinary tract tumors

Expert Team: Xi Zhijun, He Zhisong, Li Hang, Sheng Xinan, Shou Jianzhong, Xie Yi, Wang Gang, Luo Yong, Wang Yalin

Specializing in the diagnosis and treatment of hematologic malignancies such as lymphoma and multiple myeloma, the center boasts extensive expertise in managing Hodgkin lymphoma and non-Hodgkin lymphoma.

Guided by the philosophy of precision medicine, the center leverages advanced diagnostic technologies including flow cytometry and molecular genetic testing. It offers internationally cutting-edge therapies such as CAR-T cell therapy and targeted drug treatment, delivering comprehensive, globally standardized medical services to patients.

Target Diseases: Hematologic malignancies including lymphoma and multiple myeloma

Expert Team: Zhang Wei, Zhu Tienan, Wang Jingwen, Xu Chen

Led by renowned specialists in thyroid diseases and ultrasound imaging from Peking Union Medical College Hospital, our team tailors refined, individualized comprehensive treatment plans for patients with thyroid tumors.

Taking into account each patient’s age, physical condition, tumor stage, and pathological type, we adopt a three-tier MDT model with real-time participation of specialists across surgery, internal medicine, ultrasound imaging, radiology, and pathology. This multidisciplinary collaboration enables customized care and ensures high-quality medical services for all patients with thyroid neoplasms.

Expert Team: Han Chun, Li Dan, Jin Wei, Zheng Shengyao

Arion Cell Therapy Research Center was established in May 2023, committed to building an internationally advanced platform integrating research and development, translational medicine, and clinical application. The center houses five specialized laboratories and a 2,000-square-meter modern GMP facility compliant with international standards. It maintains in-depth strategic collaborations with authoritative institutions including UPMC in the United States and Peking University Cancer Hospital, continuously driving technological innovation and clinical translation in cell therapy. In research and development, the next-generation CD19-CART has demonstrated promising efficacy and safety in clinical studies, with an IND application targeted for submission by the end of 2025. The TILs program is systematically advancing through preclinical research and investigator-initiated clinical trials (IITs). The center has established partnerships with multiple industry-leading enterprises, covering the full workflow from sample processing and IND filing to clinical trial support. Leveraging core technological strengths including streamlined vein-to-vein workflow and fresh non-cryopreserved rapid manufacturing, the center enables efficient translation from innovative R&D to clinical treatment, offering novel therapeutic options and new hope for patients with hematological malignancies and solid tumors.